Astrid Schott

530 total citations
8 papers, 422 citations indexed

About

Astrid Schott is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Astrid Schott has authored 8 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Astrid Schott's work include Histone Deacetylase Inhibitors Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Astrid Schott is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Astrid Schott collaborates with scholars based in Germany, United States and Italy. Astrid Schott's co-authors include Doris Henne‐Bruns, Holger Kalthoff, Hartmut Juhl, Bernd Kremer, S. Gail Eckhardt, Wolff Schmiegel, Candice McCoy, Lia Gore, Catherine Scholz and Ilka Vogel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Astrid Schott

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Schott Germany 6 213 171 73 72 67 8 422
Gen Nishikawa Japan 8 153 0.7× 177 1.0× 117 1.6× 53 0.7× 33 0.5× 14 444
Inge Ubink Netherlands 14 145 0.7× 241 1.4× 139 1.9× 86 1.2× 93 1.4× 19 459
Masako Uno Japan 12 180 0.8× 148 0.9× 76 1.0× 87 1.2× 19 0.3× 38 528
S. Loibl Germany 10 93 0.4× 254 1.5× 146 2.0× 123 1.7× 49 0.7× 30 516
Alex Rufle Switzerland 9 96 0.5× 196 1.1× 38 0.5× 79 1.1× 140 2.1× 11 355
Ritika Kundra United States 7 289 1.4× 182 1.1× 96 1.3× 147 2.0× 50 0.7× 22 539
Qurish K. Mohemmad United States 5 304 1.4× 128 0.7× 27 0.4× 121 1.7× 42 0.6× 5 481
Susan M. Flick United States 6 113 0.5× 132 0.8× 30 0.4× 72 1.0× 21 0.3× 6 370
Stephen Brincat United States 7 195 0.9× 238 1.4× 25 0.3× 233 3.2× 36 0.5× 9 478
Meiling Zhu China 14 199 0.9× 137 0.8× 96 1.3× 156 2.2× 40 0.6× 25 410

Countries citing papers authored by Astrid Schott

Since Specialization
Citations

This map shows the geographic impact of Astrid Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Schott more than expected).

Fields of papers citing papers by Astrid Schott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Schott. The network helps show where Astrid Schott may publish in the future.

Co-authorship network of co-authors of Astrid Schott

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Schott. A scholar is included among the top collaborators of Astrid Schott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Schott. Astrid Schott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hauschild, Axel, Uwe Trefzer, Claus Garbe, et al.. (2008). Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma. Melanoma Research. 18(4). 274–278. 69 indexed citations
2.
Gore, Lia, Mace L. Rothenberg, Cindy L. O’Bryant, et al.. (2008). A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas. Clinical Cancer Research. 14(14). 4517–4525. 140 indexed citations
3.
4.
Kato, Yukihiko, David Z. Qian, Byungwoo Ryu, et al.. (2004). Restoration of transforming growth factor (TGF) beta signaling pathway in the human prostate carcinoma LNCaP cell line by the histone deacetylase inhibitor MS-275. Cancer Research. 64. 963–963. 2 indexed citations
5.
6.
Hess‐Stumpp, Holger, Jens Hoffmann, & Astrid Schott. (2004). 82 MS-275, a potent orally active inhibitor of histone deacetylases is highly active in experimental tumor models of melanoma and prostate cancer. European Journal of Cancer Supplements. 2(8). 28–28. 1 indexed citations
7.
Schott, Astrid, Ilka Vogel, Holger Kalthoff, et al.. (1998). Isolated Tumor Cells Are Frequently Detectable in the Peritoneal Cavity of Gastric and Colorectal Cancer Patients and Serve as a New Prognostic Marker. Annals of Surgery. 227(3). 372–379. 122 indexed citations
8.
Juhl, Hartmut, Holger Kalthoff, Uwe Krüger, et al.. (1994). [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].. PubMed. 65(12). 1111–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gen Nishikawa Breakdown of academic impact, for papers by Inge Ubink Breakdown of academic impact, for papers by Masako Uno Breakdown of academic impact, for papers by S. Loibl Breakdown of academic impact, for papers by Alex Rufle Breakdown of academic impact, for papers by Ritika Kundra Breakdown of academic impact, for papers by Qurish K. Mohemmad Breakdown of academic impact, for papers by Susan M. Flick Breakdown of academic impact, for papers by Stephen Brincat Breakdown of academic impact, for papers by Meiling Zhu
Rankless by CCL
2026